Thrombosis and kidney disease in cancer: comorbidities defining a very high risk patient: A position paper from the Cancer & the Kidney International Network-Reference-Cited by-同舟云学术

Thrombosis and kidney disease in cancer: comorbidities defining a very high risk patient: A position paper from the Cancer & the Kidney International Network

Published:2018-06 Issue:2-3 Volume:2 Page:37-49
ISSN:2399-3693
Container-title:Journal of Onco-Nephrology
language:en
Short-container-title:Journal of Onco-Nephrology

Author:

Launay-Vacher Vincent¹²,Scotté Florian³,Riess Hanno⁴,Ashman Neil⁵,McFarlane Philip⁶,Ribic C Christine Maria⁷,Elalamy Ismail⁸

Affiliation:

1. Service ICAR, Pitié-Salpêtrière University Hospital, Paris, France

2. Department of Nephrology, Pitié-Salpêtrière University Hospital, Paris, France

3. Medical Oncology and Supportive Care Department, Foch Hospital, Suresnes, France

4. Department of Medical Oncology and Haematology, Charité – Universitätsmedizin, Berlin, Germany

5. Department of Renal Medicine and Transplantation, The Royal London Hospital, London, UK

6. Department of Nephrology, St. Michael’s Hospital, Toronto, ON, Canada

7. Department of Medicine, McMaster University, Hamilton, ON, Canada

8. Hematology Department, Tenon Hospital, Paris, France

Abstract

Cancer & the Kidney International Network was created in 2014. The aim was to improve the management of cancer patients by developing clinical and scientific knowledge on the main topic of cancer and the kidney. Therefore, the Cancer & the Kidney International Network created a special working group: the Thrombosis, Kidney Disease, and Cancer working Group. The first step of this force was to produce a position paper on this topic by investigating the association of chronic kidney disease and venous thromboembolism in cancer patients, focusing particularly on the anticoagulant management of patients presenting these three comorbidities. The use of low-molecular-weight heparins, vitamin K agonists and oral direct anticoagulants in cancer patients with chronic kidney disease was reviewed.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/2399369318809102

Reference102 articles.

1. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

2. Epidemiology of Chronic Kidney Disease in Cancer Patients: Lessons From the IRMA Study Group

3. Reduced Estimated GFR and Cancer Mortality

4. Prevalence of Baseline Chronic Kidney Disease in Patients Presenting With Solid Renal Tumors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »;La Revue de Médecine Interne;2024-06

2. Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade;Cancers;2024-01-20

3. Management of cancer-associated thromboembolism in vulnerable population;Archives of Cardiovascular Diseases;2024-01

4. Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review;International Journal of Clinical Practice;2022-07-19

5. Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications;American Journal of Cardiovascular Drugs;2019-11-13